We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Lung Cancer

Journal Scan / Review · January 04, 2022

Antibody–Drug Conjugates in Non–Small Cell Lung Cancer

Lung Cancer


Additional Info

Lung Cancer
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach
Lung Cancer 2021 Dec 02;163(xx)59-68, S Marks, J Naidoo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading